Home
Life Science Investing Medical Device Investing

Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

August 11, 2021

- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15 th . Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Mathai Mammen Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:30 a.m. (Eastern Time) .

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .

A webcast replay will be available approximately 48-hrs after the live webcast.

View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-morgan-stanley-19th-annual-global-healthcare-conference-301354365.html

SOURCE Johnson & Johnson

News Provided by PR Newswire via QuoteMedia

medical-device-investing

The Conversation (0)

Investing News Network

28 January

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...

Scientists working in a modern medical research laboratory.

Investing News Network

05 January

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

Investing News Network

25 February 2025

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at... Keep Reading...

Investing News Network

23 January 2025

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the... Keep Reading...

CONNEQT App Launches in USA as Pulse Deliveries Commence

Investing News Network

23 January 2025

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries CommenceDownload the PDF here. Keep Reading...

Female doctor with clipboard talking to smiling female patient at hospital.

Mari-Len De Guzman

16 January 2025

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities. The groundbreaking developments in antifungal treatments specifically targeting women's health issues... Keep Reading...